Evidence
Couch In CrisisEarly Career PsychiatryHistory of PsychiatryResidents Corner. Cultural Corner. Film and Book ReviewsPoetryWriters Contest.Read More
Document this CPD
Estimated reading time: 1 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research
New Chemical Entity Improves Symptoms in Individuals With Treatment-Resistant Schizophrenia
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
- Networked Bollywood: How Star Power Globalized Hindi Cinema
- Endocannabinoid system alterations in schizophrenia: association with cannabis use and antipsychotic medication
- Neurocognition and NMDAR co-agonists pathways in individuals with treatment resistant first-episode psychosis: a 3-year follow-up longitudinal study
- Moral Progress: A Colloquium with Rahel Jaeggi
- Dual Atypical Antipsychotics in Treatment-Resistant Schizophrenia: A Correctional Case Report and Review of Literature
- Film screening: Still Here (2023)
- Variations to plasma H(2)O(2) levels and TAC in chronical medicated and treatment-resistant male schizophrenia patients: Correlations with psychopathology
- KEYNOTE: Weaving your career with the three most important threads: A guide to happily leaving academia
- Differential effects of cannabis constituents on schizophrenia-related psychosis: a rationale for incorporating cannabidiol into a schizophrenia therapeutic regimen
- Impostor Phenomenon: Another Threat to CRNA Wellness and Career Optimization
- Film Screening followed by Q&A with the Director: "Stepping Softly on the Earth", by Marcos Colón
- Efficacy of clozapine versus standard treatment in adult individuals with intellectual disability and treatment-resistant psychosis (CLOZAID): study protocol of a multicenter randomized clinical trial
- Videogame training increases clinical well-being, attention and hippocampal-prefrontal functional connectivity in patients with schizophrenia
- Blood Cell Count Ratios at Baseline are Associated with Initial Clinical Response to Clozapine in Treatment-Resistant, Clozapine-Naïve, Schizophrenia-Spectrum Disorder
- The Comparison of Lifestyles, Mental Risks, and Physical Indices among Individuals with Ultra-High Risk of Psychosis, Patients with Schizophrenia, and the General Public
- Aberrant connectivity in the hippocampus, bilateral insula and temporal poles precedes treatment resistance in first-episode psychosis: a prospective resting-state functional magnetic resonance imaging study with connectivity concordance mapping
- Aberrant connectivity in the hippocampus, bilateral insula and temporal poles precedes treatment resistance in first-episode psychosis: a prospective resting-state functional magnetic resonance imaging study with connectivity concordance mapping
- A review on the pharmacology of cariprazine and its role in the treatment of negative symptoms of schizophrenia
- Pupillary responses as a biomarker of cognitive effort and the impact of task difficulty on reward processing in schizophrenia
- Thiamine deficiency as a cause of anorexia in terminally ill cancer patients: A case of possible gastrointestinal beriberi
- Overcoming the barriers to identifying and managing treatment-resistant schizophrenia and to improving access to clozapine: A narrative review and recommendation for clinical practice
- Supporting career development for early- and mid-career professionals working in the bipolar disorder field: Key initiatives to be implemented by the International Society for Bipolar Disorders Early- and Mid-Career Committee
- First 150 years of catatonia: Looking back at its complicated history and forward to the road ahead
- Choosing the (Not So) Obvious: Careers Outside the Box
- Dual disorder: does expert clinical experience support the rationale for cariprazine use?
- Héctor Fernández-Álvarez (1944-2023)
- Positive and negative symptoms in methamphetamine-induced psychosis compared to schizophrenia: A systematic review and meta-analysis
- Twins Standing in for Co-Twins: Explanation and Speculation/Twin Research Reviews: Single v. Multiple Embryo Transfer; Neurimaging of Twins with Periventricular Nodular Heterotopia; Twin Dietary Study; New Hungarian Text on Twins/Human…
- Virtual realities, real recoveries: exploring the efficacy of 3MDR therapy for treatment-resistant PTSD
- Elevated intrinsic cortical curvature in treatment-resistant schizophrenia: Evidence of structural deformation in functional connectivity areas and comparison with alternate indices of structure
- Cultural stressors, acculturation processes, and mental health among adolescents in Korean multicultural families
- Determinants of Disability Among Individuals Living with Schizophrenia Attending Psychiatric Follow-Up Clinic in Jimma, Southwest Ethiopia: An Institution-Based Case-Control Study
- Virtual Reality-Based Simulated Hallucinations to Enhance Empathy Toward Individuals With Schizophrenia
- Chitosan/zein-based sustained-release composite films: Fabrication, physicochemical properties and release kinetics of tea polyphenols from polymer matrix
- Efficacy of Esketamine among patients with treatment resistant depression in a 'real world' health-care setting in Israel
- UBL4A alleviates the progression of intracerebral hemorrhage by regulating oxidative stress and mitochondrial damage
- From group mentoring to collective liberation: The imperative to decolonize nursing academia
- Association of cytokines levels, psychopathology and cognition among CR-TRS patients with metabolic syndrome
- Clozapine Efficacy and Adverse Drug Reactions Among a Nationwide Study of 1021 Australians Prescribed Clozapine: The ClozaGene Study
- Clozapine Efficacy and Adverse Drug Reactions Among a Nationwide Study of 1021 Australians Prescribed Clozapine: The ClozaGene Study
- Long-term persistence of the risk of agranulocytosis with clozapine compared with other antipsychotics: a nationwide cohort and case-control study in Finland
- Using Computational Phenotyping to Identify Divergent Strategies for Effort Allocation Across the Psychosis Spectrum
- Long-term persistence of the risk of agranulocytosis with clozapine compared with other antipsychotics: a nationwide cohort and case-control study in Finland
- Laser weeding: opportunities and challenges for couch grass (Elymus repens (L.) Gould) control
- Everest 1924: A Century in Review Symposium - Looking back on expeditions of Chomolungma: Mother Goddess of the Earth
- Unveiling the Multifaceted Capabilities of Endophytic Aspergillus flavus Isolated from Annona squamosa Fruit Peels against Staphylococcus Isolates and HCoV 229E-In Vitro and In Silico Investigations
- Osteoporosis management in adults with schizophrenia following index hip fracture event: a 10-year population-based retrospective cohort study, Ontario, Canada
- Trajectories of suicidal risk among individuals with first-episode psychosis: Relationship to recovery and symptoms
- The altered volume of striatum: A neuroimaging marker of treatment in first-episode and drug-naive schizophrenia
- Neuromelanin-Sensitive MRI: A Biomarker for Treatment-Resistant Schizophrenia?
- Integrating Subjective Recovery and Stigma Resistance in Individuals with Schizophrenia: A Narrative Review and Theoretical Integration
- Integrating Subjective Recovery and Stigma Resistance in Individuals with Schizophrenia: A Narrative Review and Theoretical Integration
- Atomic Force Microscopy beyond Topography: Chemical Sensing of 2D Material Surfaces through Adhesion Measurements
- Deterioration in cognitive control related mPFC function underlying development of treatment resistance in early psychosis
- Genome-Wide Association Study of Treatment-Resistant Depression: Shared Biology With Metabolic Traits
- Genome-Wide Association Study of Treatment-Resistant Depression: Shared Biology With Metabolic Traits
- An overview of the efficacy and safety of brexpiprazole for the treatment of schizophrenia in adolescents
- Factors impacting intent to seek treatment within youth at clinical high risk for psychosis
- Chemical species: the art and politics of living with(out) drugs after addiction
- Depression with comorbid borderline personality disorder - could ketamine be a treatment catalyst?
- Depression with comorbid borderline personality disorder - could ketamine be a treatment catalyst?
- Understanding Health-Promoting Behaviors and Influential Factors in Schizophrenia Patients
- Considering people at clinical high risk for psychosis with normodopaminergia: Clinical case of progression to treatment-resistant schizophrenia in three years
- Mediation of social anxiety and depression during internet-delivered treatment for social anxiety disorder
Evidence Blueprint
New Chemical Entity Improves Symptoms in Individuals With Treatment-Resistant Schizophrenia
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
New Chemical Entity Improves Symptoms in Individuals With Treatment-Resistant Schizophrenia
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
- An international research agenda for clozapine-resistant schizophrenia
- Significant improvement of psychotic symptoms in treatment-resistant schizophrenia with clozapine in an adolescent with SHINE syndrome: a case report
- Effects of film-forming Pichia and Candida yeasts on cider and wine as post-fermentation contaminants
- The longitudinal structure of negative symptoms in treatment resistant schizophrenia
- Networked Bollywood: How Star Power Globalized Hindi Cinema
- Association of DRD2, DRD4 and COMT genes variants and their gene-gene interactions with antipsychotic treatment response in patients with schizophrenia
- Cariprazine augmentation of clozapine in schizophrenia-a retrospective chart review
- Endocannabinoid system alterations in schizophrenia: association with cannabis use and antipsychotic medication
- Management of treatment resistance-Treatment-resistant schizophrenia
- Design, Development, Evaluation, and In Vivo Performance of Buccal Films Embedded with Paliperidone-Loaded Nanostructured Lipid Carriers
- Rhabdomyolysis during adjunctive treatment with cariprazine in a clozapine-resistant schizophrenia patient
- Cognition in Patients with Schizophrenia: Interplay between Working Memory, Disorganized Symptoms, Dissociation, and the Onset and Duration of Psychosis, as Well as Resistance to Treatment
- Associations of the Gut Microbiome With Treatment Resistance in Schizophrenia
- Higher orexin-A levels are associated with treatment response to clozapine in patients with schizophrenia: A cross-sectional study
- Facial Expressions Track Depressive Symptoms in Old Age
- Neurocognition and NMDAR co-agonists pathways in individuals with treatment resistant first-episode psychosis: a 3-year follow-up longitudinal study
- Moral Progress: A Colloquium with Rahel Jaeggi
- Factors associated with self-perceived treatment-resistance in bipolar disorder
- Treatment-Resistant Depression in Argentina: results from a longitudinal analysis of the TRAL Study
- Things to know about AI for your career
- Durability of deep transcranial magnetic stimulation for veterans with treatment resistant depression with comorbid suicide risk and PTSD symptoms
- Dual Atypical Antipsychotics in Treatment-Resistant Schizophrenia: A Correctional Case Report and Review of Literature
- Side effects of clozapine in older adults with treatment-resistant schizophrenia compared to younger adults
- Film screening: Still Here (2023)
- Variations to plasma H(2)O(2) levels and TAC in chronical medicated and treatment-resistant male schizophrenia patients: Correlations with psychopathology
- The Neurobiological Underpinnings of Obsessive-Compulsive Symptoms in Psychosis, Translational Issues for Treatment-Resistant Schizophrenia
- Identification and treatment of individuals with childhood-onset and early-onset schizophrenia
- Identification and treatment of individuals with childhood-onset and early-onset schizophrenia
- Schizophrenia in Autistic People with Intellectual Disabilities. Treatment and Interventions
- KEYNOTE: Weaving your career with the three most important threads: A guide to happily leaving academia
- Dr Linda Eggert named AI2050 Early Career Fellows by Schmidt Sciences
- The Role of Cerebellum in Alzheimer's Disease: A Forgotten Research Corner
- Differential effects of cannabis constituents on schizophrenia-related psychosis: a rationale for incorporating cannabidiol into a schizophrenia therapeutic regimen
- Dr Linda Eggert named AI2050 Early Career Fellow by Schmidt Sciences
- The association of SOD and HsCRP with the efficacy of sulforaphane in schizophrenia patients with residual negative symptoms
- The impact of COVID-19 vaccination on psychiatric symptoms in schizophrenia patients: A retrospective study
- Negative symptoms and cognitive impairment are associated with distinct motivational deficits in treatment resistant schizophrenia
- Impostor Phenomenon: Another Threat to CRNA Wellness and Career Optimization
- Cross-sectional study on the dissociation of decision-making capacity for antipsychotic treatment and COVID-19 vaccination in individuals with schizophrenia
- Film Screening followed by Q&A with the Director: "Stepping Softly on the Earth", by Marcos Colón
- Parenting and family life experiences of mothers diagnosed with schizophrenia within Chinese cultural context
- Efficacy of clozapine versus standard treatment in adult individuals with intellectual disability and treatment-resistant psychosis (CLOZAID): study protocol of a multicenter randomized clinical trial
- Videogame training increases clinical well-being, attention and hippocampal-prefrontal functional connectivity in patients with schizophrenia
- Sex differences in the association of treatment-resistant schizophrenia and serum interleukin-6 levels
- Blood Cell Count Ratios at Baseline are Associated with Initial Clinical Response to Clozapine in Treatment-Resistant, Clozapine-Naïve, Schizophrenia-Spectrum Disorder
- Cross-cultural adaptation and inter-rater reliability of the Schizophrenia proneness instrument adult version (SPI-A) in the Indonesian context
- The Comparison of Lifestyles, Mental Risks, and Physical Indices among Individuals with Ultra-High Risk of Psychosis, Patients with Schizophrenia, and the General Public
- The schizophrenia syndrome, circa 2024: What we know and how that informs its nature
- Aberrant connectivity in the hippocampus, bilateral insula and temporal poles precedes treatment resistance in first-episode psychosis: a prospective resting-state functional magnetic resonance imaging study with connectivity concordance mapping
- Aberrant connectivity in the hippocampus, bilateral insula and temporal poles precedes treatment resistance in first-episode psychosis: a prospective resting-state functional magnetic resonance imaging study with connectivity concordance mapping
- CONSENSUS BY THE COLLECTIVE OF PSYCHIATRISTS FOR THE CLOZAPINE UPDATE
- A review on the pharmacology of cariprazine and its role in the treatment of negative symptoms of schizophrenia
- A systematic review of clozapine for aggression and violence in patients with schizophrenia or schizoaffective disorder
- Addressing experiences of trauma within Indigenous-focused substance use residential treatment: a systematic review and environmental scan
- Pupillary responses as a biomarker of cognitive effort and the impact of task difficulty on reward processing in schizophrenia
- Empathy in the Care of Individuals With Schizophrenia: A Vital Element of Treatment
- Obsessive-Compulsive Symptoms and Disorder in Clozapine-treated Schizophrenia
- Long-term outcomes of delayed clozapine initiation in treatment-resistant schizophrenia: a multicenter retrospective cohort study
- Once-daily versus divided dosing regimens of clozapine: A cross-sectional study in Singapore
- Thiamine deficiency as a cause of anorexia in terminally ill cancer patients: A case of possible gastrointestinal beriberi
- Cultural family processes, depressive symptoms, and suicidal ideation: A longitudinal study of Asian American youths
- Overcoming the barriers to identifying and managing treatment-resistant schizophrenia and to improving access to clozapine: A narrative review and recommendation for clinical practice
- Oxford early career researchers shine in Parliamentary competition
- Supporting career development for early- and mid-career professionals working in the bipolar disorder field: Key initiatives to be implemented by the International Society for Bipolar Disorders Early- and Mid-Career Committee